Atopic Disease, Particularly Asthma, Linked to Decreased Risk of COVID-19 Infection in UK Adults
January 07, 2022

Adults with atopic disease and asthma had a 38% decreased risk of COVID-19 infection, according to a new UK study.

Guideline Toplines: 2021 Clinical Focus Collection
December 08, 2021

The Guideline Toplines slide-show feature offers busy primary care physicians at-a-glance summaries of new and updated clinical guidelines across therapeutic areas.

Multiple-inhaler Triple Therapy for Asthma in Adults Comes with High Risk of Discontinuation
October 25, 2021

Approximately three-quarters of asthma patients who began multiple-inhaler triple therapy had stopped using it 6 months later, according to a new study.

Study: Hispanic Adults, Women, and Older E-cigarette Users Face Higher Odds of Asthma and COPD
October 20, 2021

CHEST 2021: Study shows vaping raises the odds of developing asthma and COPD, especially in older adults, women, and Hispanic persons.

Biologics Reduce Severe Asthma Exacerbations in Real-world Study of Vulnerable Patients
October 18, 2021

CHEST2021: The CHRONICLE study of biologics to treat severe asthma found reductions in exacerbations of more than 50% in patient groups not included in clinical trials.

Dupilumab Associated with Reduced Oral Corticosteroids in Severe Asthma, Regardless of Baseline OCS Dose
October 18, 2021

In patients with severe asthma dependent on OCS, dupilumab reduced OCS dose and improved the odds of no longer requiring OCS, suggests research presented at CHEST 2021.

Tezepelumab May Improve Peak Expiratory Flow in Patients with Severe Asthma, Suggests Analysis of NAVIGATOR Trial
October 14, 2021

CHEST 2021: Patients with severe asthma who received tezepelumab compared with placebo demonstrated rapid improvement in morning and evening peak expiratory flow.

Work Environment May Trigger Asthma in Some Employees, New Research Suggests
September 21, 2021

A variety of exposures in the work environment can cause asthma in some employees, according to new research presented at ERS Virtual International Congress 2021.

Fixed-dose Albuterol/Budesonide Superior to Components for Asthma in Dual Phase 3 Trials
September 13, 2021

The albuterol/budesonide combination significantly reduced the risk of severe exacerbations and improved lung function in mild-to-moderate asthma.

Smoking, NSAID-exacerbated Respiratory Disease Among Risk Factors for Severe Asthma Identified in New Study
August 03, 2021

A new study found several risk factors associated with severe adult-onset asthma, including smoking, NSAID-exacerbated respiratory disease, and sibling count.